@haidut
Metformin lowers iron, copper (could be good) ,influences zinc, magnesium, B9, B12, B1, chromium but restores Randle cycle to burn glucose
zinc could lower demand on metformin
metals and gallstones
https://www.sciencedirect.com/science/article/pii/S1015958424011527
The roles of metal ions in gallstones formation
Author links open overlay panelKuinan Tong 1, Chao Jing 1, Tingting Wang, Kun Liu, Wei Guo, Zhongtao Zhang
https://doi.org/10.1016/j.asjsur.2024.05.243
https://ars.els-cdn.com/content/image/1-s2.0-S1015958424011527-gr1.jpg
https://ars.els-cdn.com/content/image/1-s2.0-S1015958424011527-gr2.jpg
AI Metformin disrupts the Randle cycle (glucose-fatty acid cycle) by inhibiting fatty acid oxidation and reducing free fatty acid (FFA) levels, thereby promoting glucose utilization over fats. By inhibiting this cycle, metformin reduces insulin resistance, decreases hepatic glucose production, and restores the body’s ability to utilize glucose efficiently.
Key Aspects of Metformin and the Randle Cycle:Randle Cycle
Overview: The Randle cycle is the competition between glucose and fatty acids for energy oxidation, where high fat levels inhibit glucose uptake and oxidation, promoting insulin resistance.
Mechanism of Action: Metformin reduces the oxidation of long-chain fatty acids, specifically in red muscle, which restores glucose oxidation and reduces the reliance on fat as a primary fuel source.
Impact on Diabetes: By inhibiting this cycle, metformin helps lower elevated blood glucose levels and reduces hypertriglyceridemia, which are common in type 2 diabetes.
Insulin Sensitivity: Metformin-induced inhibition of the Randle cycle improves overall metabolic flexibility and improves insulin sensitivity, enhancing muscle and peripheral uptake of glucose.
Energy Balance: The drug helps reverse the overactive Randle cycle that occurs in obese or diabetic patients, improving the balance between glucose and fat utilization.
Both metformin and zinc appear to have protective effects against gallstones, often through improving metabolic health and reducing gallbladder inflammation. While they are frequently used together for diabetes management, their individual roles in gallbladder health are distinct.
Metformin and Gallstones
**Reduced Risk: Long-term use of metformin is associated with a significantly lower risk of developing gallstones in diabetic patients.
Mechanism: Metformin helps by improving insulin sensitivity and gallbladder motility, which prevents the "stasis" of bile that leads to stone formation.**
Animal Research Warning: In some mouse studies, while metformin prevented stones, it was also linked to porcelain gallbladder (mucosal calcification), though it is unclear if this occurs in humans.
Zinc and Gallstones
Zinc Deficiency Connection: Patients with gallstone disease often have significantly lower serum zinc levels.
Protective Properties: Zinc may help prevent gallstones by reducing free radical formation and protecting against oxidative stress in the liver and gallbladder.
Bile Flow: Supplementation has been shown in animal models to suppress liver fibrosis and improve the composition of bile, potentially aiding in stone prevention.
Taking Zinc and Metformin TogetherSynergy: For diabetic patients, combining zinc and metformin can be more effective than metformin alone for overall metabolic health.
Safety: There are no known direct drug interactions between zinc supplements and metformin.
Metabolic Benefit: Both substances help lower HbA1c levels and improve lipid profiles (cholesterol/triglycerides), both of which are key risk factors for gallstone formation.
Zinc deficiency causes significant muscle loss (muscle atrophy), reduced muscle strength, and impaired muscle repair, as zinc is essential for protein synthesis, cell growth, and tissue regeneration. Severe deficiency increases muscle protein breakdown (catabolism), reduces muscle mass, and is an independent factor for sarcopenia.
Zinc Deficiency and Muscle Loss Mechanisms:Reduced Protein Synthesis & Regeneration: Low zinc levels restrict muscle regeneration by slowing down myogenesis (muscle cell formation) and impairing muscle cell activation.
Increased Breakdown: Deficiency disrupts skeletal muscle proteostasis, activating the ubiquitin-proteasome system, which breaks down muscle proteins.
Mitochondrial Dysfunction: Zinc is crucial for mitochondrial health; its lack can lead to impaired mitochondrial function, reducing energy supply (ATP) for muscle cells.
Hormonal Imbalance: Zinc deficiency can lead to lower levels of testosterone and growth hormone, which are essential for maintaining muscle mass
.Chronic Diseases & Aging: In patients with chronic liver disease, zinc deficiency is an independent predictor of sarcopenia (age-dependent loss of muscle).
Zinc acts as a modulator of AMPK (AMP-activated protein kinase), a key cellular energy sensor, influencing its activity in ways that can be beneficial or harmful depending on the context. It helps maintain metabolic homeostasis and is crucial for muscle protein synthesis, with zinc deficiency often increasing susceptibility to muscle atrophy via AMPK.
Key Aspects of Zinc-AMPK Interaction:Muscle Metabolism: AICAR (an AMPK activator) increases intracellular zinc levels, and zinc-depleted conditions lead to greater muscle atrophy under stress.
Neural Protection: Zinc can regulate glucose metabolism in spinal cord neurons via the AMPK signaling pathway. It has been shown to induce autophagy and protect against neuronal apoptosis following injury.
Neurotoxicity Mechanism: Excessive free zinc (zinc excitotoxicity) can trigger neuronal death by overactivating the LKB1-AMPK-Bim cascade, leading to ATP depletion.
Metabolic Regulation: Zinc affects the AMPK pathway by modifying the Thr172 phosphorylation of AMPK, which in turn regulates downstream targets like ACC (acetyl-CoA carboxylase).Cellular Energy: Studies suggest zinc exposure can influence energy metabolism by activating the AMPK pathway.
In summary, zinc helps regulate AMPK activity, with appropriate levels aiding in energy management and tissue health, while excessive free zinc can trigger toxic, AMPK-dependent cell death.
Signs of Zinc-Related Muscle Issues: Difficulty gaining or maintaining muscle mass.Reduced endurance and increased muscle fatigue.Slow recovery after exercise.Slow wound healing.
Important Context:Athletes: Athletes are susceptible to zinc loss through excessive sweating and elevated metabolic demand, necessitating adequate intake to avoid muscle performance decline.
Cancer Cachexia: Interestingly, excess zinc accumulation in muscles—driven by a protein called ZIP14 during severe illnesses like cancer—can also lead to severe muscle wasting, not just deficiency.
Ensuring adequate zinc intake through diet (meat, shellfish, legumes, nuts) is key to preventing this type of muscle loss.
Insulin-degrading enzyme (IDE), or insulinase, is a zinc-dependent metalloproteinase (~110 kDa) that breaks down insulin, amylin, and other small polypeptides. It plays a crucial role in regulating insulin levels and is a key target in diabetes research. It is often found in the cytoplasm of human cells and acts with a unique (HXXEH) zinc-binding motif.
Key Details About Zinc Insulinase (IDE):Function: Degrades insulin, amylin, glucagon, and amyloid (\beta ) (A(\beta )).
Structure: It belongs to the M16 metalloprotease family and requires zinc as a cofactor for activity.
Location: Found in mammalian cytosol, peroxisomes, and endosomes.
Alternative Names: Insulysin, insulin protease, or bacterial protease III (in E. coli).
Medical Relevance: Because it degrades insulin, IDE is studied for its impact on insulin resistance and type 2 diabetes.
Key Characteristics:Active Site: Unlike many zinc proteases, it uses an "inverted" (HXXEH) motif to bind zinc.
pH Stability: The enzyme has an optimal pH around (7.0).Inhibitors: Its activity can be inhibited by endogenous factors or specific compounds.
